Review Series on Acute Lymphoblastic Leukemia (ALL)
Dr. Hervé Dombret and Dr. Mark Litzow discuss recent immunotherapy advances for Acute Lymphoblastic Leukemia (ALL), noting innovative treatments like blinatumomab and inotuzumab that show high survival and remission rates, particularly in elderly patients. The conversation…